| Literature DB >> 24791224 |
Hang Xing1, Kevin Hwang2, Ji Li1, Seyed-Fakhreddin Torabi3, Yi Lu4.
Abstract
This review highlights recent progress in developing DNA aptamers for personalized medicine, with more focus on in vivo studies for potential clinical applications. Examples include design of aptamers in combination with DNA nanostructures, nanomaterials, or microfluidic devices as diagnostic probes or therapeutic agents for cancers and other diseases. The use of aptamers as targeting agents in drug delivery is also covered. The advantages and future directions of such DNA aptamer-based technology for the continued development of personalized medicine are discussed.Entities:
Keywords: DNA aptamer; cancer; diagnosis; personalized medicine; targeted delivery; therapy
Year: 2014 PMID: 24791224 PMCID: PMC4001932 DOI: 10.1016/j.coche.2014.01.007
Source DB: PubMed Journal: Curr Opin Chem Eng ISSN: 2211-3398 Impact factor: 5.163